GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bruker Corp (NAS:BRKR) » Definitions » Cyclically Adjusted PB Ratio

Bruker (Bruker) Cyclically Adjusted PB Ratio : 12.07 (As of Apr. 27, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Bruker Cyclically Adjusted PB Ratio?

As of today (2024-04-27), Bruker's current share price is $80.97. Bruker's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $6.71. Bruker's Cyclically Adjusted PB Ratio for today is 12.07.

The historical rank and industry rank for Bruker's Cyclically Adjusted PB Ratio or its related term are showing as below:

BRKR' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 4.78   Med: 8.02   Max: 16.83
Current: 12.07

During the past years, Bruker's highest Cyclically Adjusted PB Ratio was 16.83. The lowest was 4.78. And the median was 8.02.

BRKR's Cyclically Adjusted PB Ratio is ranked worse than
93.42% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 2.07 vs BRKR: 12.07

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bruker's adjusted book value per share data for the three months ended in Dec. 2023 was $9.487. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $6.71 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bruker Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Bruker's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bruker Cyclically Adjusted PB Ratio Chart

Bruker Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.71 10.61 14.71 10.96 10.95

Bruker Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.96 12.30 11.29 9.35 10.95

Competitive Comparison of Bruker's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Bruker's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bruker's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bruker's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bruker's Cyclically Adjusted PB Ratio falls into.



Bruker Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bruker's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=80.97/6.71
=12.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bruker's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Bruker's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=9.487/129.4194*129.4194
=9.487

Current CPI (Dec. 2023) = 129.4194.

Bruker Quarterly Data

Book Value per Share CPI Adj_Book
201403 5.139 99.695 6.671
201406 5.238 100.560 6.741
201409 4.793 100.428 6.177
201412 4.545 99.070 5.937
201503 4.239 99.621 5.507
201506 4.526 100.684 5.818
201509 4.529 100.392 5.839
201512 4.391 99.792 5.695
201603 4.319 100.470 5.563
201606 4.107 101.688 5.227
201609 4.326 101.861 5.496
201612 4.294 101.863 5.456
201703 4.531 102.862 5.701
201706 4.757 103.349 5.957
201709 4.686 104.136 5.824
201712 4.654 104.011 5.791
201803 5.007 105.290 6.154
201806 4.968 106.317 6.048
201809 5.219 106.507 6.342
201812 5.725 105.998 6.990
201903 5.823 107.251 7.027
201906 5.566 108.070 6.666
201909 5.490 108.329 6.559
201912 5.882 108.420 7.021
202003 5.937 108.902 7.056
202006 5.862 108.767 6.975
202009 6.215 109.815 7.325
202012 6.324 109.897 7.447
202103 6.386 111.754 7.395
202106 6.633 114.631 7.489
202109 7.091 115.734 7.929
202112 7.101 117.630 7.813
202203 6.812 121.301 7.268
202206 6.543 125.017 6.773
202209 6.358 125.227 6.571
202212 7.576 125.222 7.830
202303 8.042 127.348 8.173
202306 8.386 128.729 8.431
202309 8.285 129.860 8.257
202312 9.487 129.419 9.487

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bruker  (NAS:BRKR) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bruker Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Bruker's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bruker (Bruker) Business Description

Traded in Other Exchanges
Address
40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives a majority of its revenue from Europe.
Executives
Frank H Laukien director, 10 percent owner, officer: CEO, President C/O BRUKER DALTONICS, 40 MANNING ROAD, BILLERICA MA 01821
Marc A Kastner director BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Cynthia M Friend director C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Richard A Packer director 9 KENDALL DRIVE, WESTBOROUGH MA 01581
Philip Ma director C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Mark Munch officer: Pres. Bruker Nano Inc. BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Juergen Srega officer: Group President Bruker CALID BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Burkhard Prause officer: Pres. & CEO, Bruker EST BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Bonnie H Anderson director 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO CA 94080
Martin Gilles Gerard Jean director BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Falko Busse officer: President, BioSpin Group 40 MANNING ROAD, BILLERICA MA 01821
Gerald N Herman officer: Vice President, Corp Contr. 55 EXECUTIVE DRIVE, HUDSON NH 03051
Ingen Chris Van director 395 PAGE MILL RD, MS A3 18, PALO ALTO CA 94306
Richard Kniss director 395 PAGE MILL RD, MS A3 18, PALO ALTO CA 94306
Adelene Q Perkins director C/O INFINITY PHARMACEUTICALS, INC., 780 MEMORIAL DRIVE, CAMBRIDGE MA 02139